BeiGene, Ltd. American Depositary Shares
BGNE Real Time Price USDRecent trades of BGNE by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by BGNE's directors and management
Government lobbying spending instances
-
$170,000 Jan 24, 2025 Issue: Health Issues
-
$160,000 Oct 20, 2024 Issue: Health Issues
-
$160,000 Jul 22, 2024 Issue: Health Issues
-
$240,000 Apr 22, 2024 Issue: Health Issues
-
$140,000 Jan 22, 2024 Issue: Health Issues
-
$170,000 Oct 20, 2023 Issue: Health Issues
-
$90,000 Apr 20, 2022 Issue: Health Issues
-
$80,000 Jan 20, 2022 Issue: HEALTH ISSUES
-
$80,000 Oct 20, 2021 Issue: HEALTH ISSUES
-
$80,000 Jul 19, 2021 Issue: HEALTH ISSUES
-
$80,000 Apr 20, 2021 Issue: HEALTH ISSUES
-
$80,000 Jan 20, 2021 Issue: None
-
$40,000 Oct 20, 2020 Issue: None
-
$20,000 Jul 20, 2020 Issue: Health Issues
-
$50,000 Apr 17, 2020 Issue: Health Issues
Estimated quarterly lobbying spending
BGNE Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to BGNE
Number of mentions of BGNE in WallStreetBets Daily Discussion
Recent picks made for BGNE stock on CNBC
ETFs with the largest estimated holdings in BGNE
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BGNE Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.